Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: Nicotinamide Riboside in Ulcerative Colitis [NA]

View source ↗

Summary

A clinical trial evaluating nicotinamide riboside for Ulcerative Colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: University of Pittsburgh | Conditions: Ulcerative Colitis | NA | Status: RECRUITING